Table 1.
Clinical features and baseline plasma lipid concentrations of the two groups of subjects with primary hypercholesterolemia (HCH) treated with BBR/P/RR or EZE for six months
| BBR/P/RR | EZE | P | |
|---|---|---|---|
| Males/Females |
62/90 |
31/45 |
|
| Age (years) |
57.3 ± 12.1 |
58.3 ± 12.3 |
NS |
| BMI (kg/m2) |
23.9 ± 2.9 |
23.5 ± 2.8 |
NS |
| Arterial hypertension |
30.2% |
31.5% |
NS |
| Carotid atherosclerosis* |
26.3, 48.0, 3.9% |
31.5, 51.3, 3.9% |
NS |
| TC (mmol/L) |
7.63 ± 0.50 |
7.72 ± 0.49 |
NS |
| LDL-C (mmo/L) |
5.36 ± 0.48 |
5.36 ± 0.52 |
NS |
| HDL-C (mmo/L) |
1.55 ± 0.35 |
1.57 ± 0.34 |
NS |
| non-HDL-C (mmol/L) |
6.07 ± 0.54 |
6.15 ± 0.55 |
NS |
| TG (mmol/L)† | 1.46 (1.22-1.90) | 1.67 (1.24-2.12) | NS |
*Percent of subjects with increased intima-media thickness, with fibrous-calcific plaques with less than 30% stenosis and with fibrous-calcific plaques with 30-40% stenosis, respectively. †Median (interquartile range). NS: not significant.